Effectiveness of Pramipexole for Treatment-Resistant Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2007

Study Completion Date

April 30, 2008

Conditions
Depression
Interventions
DRUG

Pramipexole (Mirapex)

pramipexole 0.5mg tablets qd and titrated per protocol

DRUG

Placebo

sugar pill

Trial Locations (1)

02114

Depression Clinical and Research Program, Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00231959 - Effectiveness of Pramipexole for Treatment-Resistant Depression | Biotech Hunter | Biotech Hunter